Literature DB >> 6165784

Viral-induced leukocyte interferon in vesicle fluid from lesions of recurrent herpes labialis.

J C Overall, S L Spruance, J A Green.   

Abstract

Antiviral activity characterized as human interferon (HuIFN) was demonstrated in vesicle fluid from lesions of recurrent herpes labialis in 18 of 19 otherwise healthy patients. High titers (geometric mean, 29,200 units) were present during the early course of lesion development. Antiviral activity in vesicle fluid was neutralized by antibody to leukocyte (types I) HuIFN (HuIFN-alpha) in the eight patients in whom it was tested. These results indicate that HuIFN-alpha is present in the local lesions of recurrent herpes labialis. HuIFN may have a role in the pathogenesis of recurrent herpesvirus infections.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6165784     DOI: 10.1093/infdis/143.4.543

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

Review 1.  Clinical pharmacokinetics of interferons.

Authors:  R J Wills
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  Independent and cooperative antiviral actions of beta interferon and gamma interferon against herpes simplex virus replication in primary human fibroblasts.

Authors:  Tao Peng; Jia Zhu; Yon Hwangbo; Lawrence Corey; Roger E Bumgarner
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

3.  Evolution of recurrent herpes simplex lesions. An immunohistologic study.

Authors:  A L Cunningham; R R Turner; A C Miller; M F Para; T C Merigan
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

4.  Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high-prevalence population.

Authors:  W E Lafferty; S Krofft; M Remington; R Giddings; C Winter; A Cent; L Corey
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

5.  Pathogenesis of herpes simplex labialis: correlation of vesicle fluid interferon with lesion age and virus titer.

Authors:  S L Spruance; J A Green; G Chiu; T J Yeh; G Wenerstrom; J C Overall
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

6.  Spontaneous interferon-alpha antibodies in a patient with pure red cell aplasia and recurrent cutaneous carcinomas.

Authors:  O Prümmer; N Frickhofen; W Digel; H Heimpel; F Porzsolt
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

7.  Rapid host immune response and viral dynamics in herpes simplex virus-2 infection.

Authors:  Joshua T Schiffer; Lawrence Corey
Journal:  Nat Med       Date:  2013-03       Impact factor: 53.440

8.  Evasion of the mucosal innate immune system by herpes simplex virus type 2.

Authors:  Tao Peng; Jia Zhu; Alexis Klock; Khamsone Phasouk; Meei-Li Huang; David M Koelle; Anna Wald; Lawrence Corey
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

Review 9.  Recent progress in herpes simplex virus immunobiology and vaccine research.

Authors:  David M Koelle; Lawrence Corey
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

10.  Receptor dynamics of closely related ligands: "fast' and "slow' interferons.

Authors:  G Uzé; K E Mogensen; M Aguet
Journal:  EMBO J       Date:  1985-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.